PPMD & Community Partners Submit Letter to FDA Encouraging Appropriate Regulatory Flexibility in SRP-9001 Review ...
PPMD Joins Duchenne Parent Project aps Endocrine & Osteoporosis International Professional Care Meeting ...
How to Submit Written Testimony for the SRP-9001 FDA Advisory Committee Meeting – Deadline May 5th ...
NS Pharma Announces FDA Clearance of IND for Clinical Trial of NS-089/NCNP-02 Exon 44 Skipping Candidate ...
